Gentamicin and tobramycin. Clinical pharmacokinetics and nephrotoxicity. Aspects on assay techniques.
D000362:Agar; D000617:Aminoglycosides; D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism*; D005839:Gentamicins / Q000009:adverse effects / Q000378:metabolism* / Q000627:therapeutic use; D006801:Humans; D005779:Immunodiffusion; D007668:Kidney / Q000187:drug effects* / Q000473:pathology; D007677:Kidney Function Tests; D014031:Tobramycin / Q000009:adverse effects / Q000378:metabolism* / Q000627:therapeutic use
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D000362:Agar; D014031:Tobramycin